Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Myofibroma × Laparoscopy × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Colorectal Neoplasms 15 Rectal Neoplasms 14 Colonic Neoplasms 14 Stomach Neoplasms 13 Ovarian Neoplasms 7 Neoplasms 5 Gastrointestinal Stromal Tumors 4 Endometrial Neoplasms 4 Uterine Cervical Neoplasms 3 Pancreatic Neoplasms 3 Carcinoma, Renal Cell 3 Carcinoma, Hepatocellular 3 Neoplastic Cells, Circulating 2 Kidney Neoplasms 2 Fallopian Tube Neoplasms 2 Carcinoma, Ovarian Epithelial 2 Venous Thrombosis 1 Uterine Neoplasms 1 Urinary Incontinence 1 Surgical Wound Infection 1 Sexual Dysfunction, Physiological 1 Robotic 1 Prostatic Neoplasms 1 Polycystic Ovary Syndrome 1 Peritoneal Neoplasms 1 Ovarian Cysts 1 Ornithine Carbamoyltransferase Deficiency Disease 1 Obesity, Morbid 1 Neurologic Manifestations 1 Neuroendocrine Tumors 1

Interventions

relugolix 3 Uterine Myomectomy 3 Saline Solution 3 Hysterectomy 3 dienogest 2 carbetocin 2 Uterine Artery Embolization 2 Tranexamic Acid 2 Tourniquets 2 Misoprostol 2 Lidocaine 2 Hysteroscopy 2 Ascorbic Acid 2 ulipristal 1 telapristone acetate 1 remimazolam 1 ramosetron 1 pirfenidone 1 estradiol, norethindrone drug combination 1 Vasopressins 1 Triptorelin Pamoate 1 Tablets 1 Surveys and Questionnaires 1 Surgical Procedures, Operative 1 Sodium Chloride 1 Sevoflurane 1 Respiration, Artificial 1 Remifentanil 1 Propofol 1 Population Groups 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06067971 2025-09-12

ENDORA2

University Hospital, Clermont-Ferrand

Phase NA Completed

Myofibroma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡